Skip to main content
SpringerLink
Log in

Challenges in Polymer Therapeutics

State of the Art and Prospects of Polymer Drugs

  • Chapter
Polymer Drugs in the Clinical Stage

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 519))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Langer, R., 1998, Drug delivery and targeting. Nature 392:5–10.

    PubMed  CAS  Google Scholar 

  2. Northfelt, D. W., B. J. Dezube, J. A. Thommes, B. J. Miller, M. A. Fischl, A. FriedmanKien, L. D. Kaplan, C. Du Mond, R. D. Mamelok and D. H. Henry, 1998, Pegylatedliposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi’s sarcoma: results of a randomized phase III clinical trial. J. Clin. Oncol. 16:2445–2451.

    PubMed  CAS  Google Scholar 

  3. Rosenblum, M. G. and G. N. Hortobagyi, 1986, Pharmacokinetics and tissue disposition of the biological response modifier BAY i 7433 (copovithane) in patients with cancer. Cancer Chemother. Pharmacol. 18:247–251.

    PubMed  CAS  Google Scholar 

  4. Duncan, R., S. Gac-Breton, R. Keane, R. Musila, Y. N. Sat, R. Satchi and F. Searle, 2001, Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J. Control. Release 74:135–146.

    Article  PubMed  CAS  Google Scholar 

  5. Kabanov, A. V. and V. Alakhov, 2002, Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Cr Rev Ther Dr Targ 19:1–73.

    CAS  Google Scholar 

  6. Maynard, C., R. Swenson, J. A. Paris, J. S. Martin, A. P. Hallstrom, M. D. Cerqueira and W. D. Weaver, 1998, Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group. Am Heart J 135:797–804.

    Article  PubMed  CAS  Google Scholar 

  7. Fournier, C., B. Hecquet, P. Bouffard, M. Vert, A. Caty, M. O. Vilain, L. Vanseymortier, S. Merle, A. Krikorian, J. L. Lefebvre and et al., 1991, Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors. Cancer Res 51:5384–5391.

    PubMed  CAS  Google Scholar 

  8. Einmahl, S., S. Capancioni, K. Schwach-Abdellaoui, M. Moeller, F. Behar-Cohen and R. Gurny, 2001, Therapeutic applications of viscous and injectable poly(ortho esters). Adv. Drug Deliv. Rev. 53:45–73.

    Article  PubMed  CAS  Google Scholar 

  9. Kattan, J., J. P. Droz, P. Couvreur, J. P. Marino, A. Boutan-Laroze, P. Rougier, P. Brault, H. Vranckx, J. M. Grognet, X. Morge and et al., 1992, Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest New Drugs 10:191–199.

    Article  PubMed  CAS  Google Scholar 

  10. Seymour, L. W., S. P. Olliff, C. J. Poole, P. G. De Takats, R. Orme, D. R. Ferry, H. Maeda, T. Konno and D. J. Kerr, 1998, A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) — neocarzinostatin] in the treatment of primary hepatocellular carcinoma. Int. J. Oncol. 12:1217–1223.

    PubMed  CAS  Google Scholar 

  11. Maeda, H., 2001, SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 46:169–185.

    Article  PubMed  CAS  Google Scholar 

  12. Ardizzone, S., M. Petrillo, P. Molteni, S. Desideri and G. Bianchi Porro, 1995, Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study. J. Clin. Gastroenterol. 21:287–289.

    PubMed  CAS  Google Scholar 

  13. Schenk, J. F., P. Radziwon, S. Morsdorf, P. Eckenberger and H. K. Breddin, 1999, Effects of aprosulate, a novel synthetic glycosaminoglycan, on coagulation and platelet function parameters: a prospective, randomized phase I study. Clin. Appl. Thromb. Hemost. 5:192–197.

    PubMed  CAS  Google Scholar 

  14. Payne, L. G., S. A. Jenkins, A. L. Woods, E. M. Grund, W. E. Geribo, J. R. Loebelenz, A. K. Andrianov and B. E. Roberts, 1998, Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine. Vaccine 16:92–98.

    Article  PubMed  CAS  Google Scholar 

  15. Payne, L. G., S. A. Jenkins, A. Andrianov and B. E. Roberts, 1995, Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery. Pharm Biotechnol 6:473–493.

    PubMed  CAS  Google Scholar 

  16. Andrianov, A. K., J. Chen and L. G. Payne, 1998, Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions. Biomaterials 19:109–115.

    Article  PubMed  CAS  Google Scholar 

  17. Payne, L. G. and A. K. Andrianov, 1998, Protein release from polyphosphazene matrices. Adv Drug Deliv Rev 31:185–196.

    PubMed  Google Scholar 

  18. Song, J., C. H. Suh, Y. B. Park, S. H. Lee, N. C. Yoo, J. D. Lee, K. H. Kim and S. K. Lee, 2001, A phase I/IIa study on intra-articular injection of holmium-166-chitosan complex for the treatment of knee synovitis of rheumatoid arthritis. Eur. J. Nucl. Med. 28:489–497.

    Article  PubMed  CAS  Google Scholar 

  19. Pittler, M. H., N. C. Abbot, E. F. Harkness and E. Ernst, 1999, Randomized, double-blind trial of chitosan for body weight reduction. Eur. J. Clin. Nutr.53:379–381.

    Article  PubMed  CAS  Google Scholar 

  20. Nekrasov, A. V., N. G. Puchkova, R. I. Attaullakhanov, R. V. Petrov and A. S. Ivanova, 1996, Compounds having immunostimulating activity and methods of use thereof., 5503830

    Google Scholar 

  21. El’shina, G. A., M. A. Gorbunov, T. A. Bektimirov, N. I. Lonskaia, L. I. Pavlova, A. A. Nikul’shin, R. M. Khaitov, A. V. Nekrasov, A. S. Ivanova, M. N. Matrosovich and N. G. Puchkova, 2000, [The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren]. Zh. Mikrobiol. Epidemiol. Immunobiol.:50–54.

    Google Scholar 

  22. Kataoka, K., A. Harada and Y. Nagasaki, 2001, Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47:113–131.

    Article  PubMed  CAS  Google Scholar 

  23. Katayose, S. and K. Kataoka, 1997, Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconj. Chem. 8:702–707.

    CAS  Google Scholar 

  24. Kwon, G. S. and K. Kataoka, 1995, Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Delivery Rev. 16:295–309.

    Article  CAS  Google Scholar 

  25. Yokoyama, M., M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka and S. Inoue, 1990, Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 50:1693–1700.

    PubMed  CAS  Google Scholar 

  26. Seymour, L., K. Kataoka and A. Kabanov, 1998, Cationic block copolymers as selfassembling vectors for gene delivery, In Self-assembling Complexes for Gene Delivery. From Laboratory to Clinical Trial (A. Kabanov, P. Felgner and L. Seymour eds), John Wiley & Sons, Chichester, UK pp 219–239.

    Google Scholar 

  27. Harada, A. and K. Kataoka, 1997, Formation of stable and monodispersive polyion complex micelles in aqueous medium from poly(L-lysine) and poly(ethylene glycol)-poly(aspartic acid) block copolymer. J. Macromol. Sci., Pure Appl. Chem. A34:2119–2133.

    CAS  Google Scholar 

  28. Harada, A. and K. Kataoka, 1998, Novel polyion complex micelles entrapping enzyme molecules in the core: preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium. Macromolecules 31:288–294.

    Article  CAS  Google Scholar 

  29. Harada, A. and K. Kataoka, 1999, Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers. Science 283:65–67.

    Article  PubMed  CAS  Google Scholar 

  30. Harada, A. and K. Kataoka, 1999, On-Off control of enzymatic activity synchronizing with reversible formation of supramolecular assembly from enzyme and charged block copolymers. J. Am. Chem. Soc. 121:9241–9242.

    CAS  Google Scholar 

  31. Harada, A. and K. Kataoka, 1999, Novel polyion complex micelles entrapping enzyme molecules in the core. 2. Characterization of the micelles prepared at nonstoichiometric mixing ratios. Langmuir 15:4208–4212.

    CAS  Google Scholar 

  32. Harada, A., H. Togawa and K. Kataoka, 2001, Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-Lysine) block copolymers. Eur. J. Pharm. Sci. 13:35–42.

    Article  PubMed  CAS  Google Scholar 

  33. Dash, P. R., V. Toncheva, E. Schacht and L. W. Seymour, 1997, Synthetic polymers for vectorial delivery of DNA: characterization of polymer-DNA complexes by photon correlation spectroscopy and stability to nuclease degradation and disruption by polyanions in vitro. J. Controlled Release 48:269–276.

    Article  CAS  Google Scholar 

  34. Dekie, L., V. Toncheva, P. Dubruel, E. H. Schacht, L. Barrett and L. W. Seymour, 2000, Poly-L-glutamic acid derivatives as vectors for gene therapy. J Control Release 65:187–202.

    Article  PubMed  CAS  Google Scholar 

  35. Oupicky, D., C. Konak, K. Ulbrich, M. A. Wolfert and L. W. Seymour, 2000, DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J Control Release 65:149–171.

    PubMed  CAS  Google Scholar 

  36. Read, M. L., T. Etrych, K. Ulbrich and L. W. Seymour, 1999, Characterisation of the binding interaction between poly(L-lysine) and DNA using the fluorescamine assay in the preparation of non-viral gene delivery vectors. FEBS Lett 461:96–100.

    Article  PubMed  CAS  Google Scholar 

  37. Benns, J. M., J. S. Choi, R. I. Mahato, J. S. Park and S. W. Kim, 2000, pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjug. Chem. 11:637–645.

    Article  PubMed  CAS  Google Scholar 

  38. Choi, Y. H., F. Liu, J.-S. Kim, Y. K. Choi, J. S. Park and S. W. Kim, 1998, Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J. Contr. Release 54:39–48.

    Google Scholar 

  39. Choi, Y. H., F. Liu, J. S. Park and S. W. Kim, 1998, Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. Bioconjug Chem 9:708–718.

    Article  PubMed  CAS  Google Scholar 

  40. Choi, Y. H., F. Liu, J. S. Choi, S. W. Kim and J. S. Park, 1999, Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. Hum Gene Ther 10:2657–65.

    Article  PubMed  CAS  Google Scholar 

  41. Allen, C., D. Maysinger and A. Eisenberg, 1999, Nano-engineering block copolymer aggregates for drug delivery. Coll. Surfaces, B: Biointerfaces 16:3–27.

    CAS  Google Scholar 

  42. Kabanov, A. V., V. P. Chekhonin, V. Y. Alakhov, E. V. Batrakova, A. S. Lebedev, N. S. Melik-Nubarov, S. A. Arzhakov, A. V. Levashov, G. V. Morozov, E. S. Severin and V. A. Kabanov, 1989, The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett. 258:343–345.

    Article  PubMed  CAS  Google Scholar 

  43. Kabanov, A. V., S. V. Vinogradov, Y. G. Suzdaltseva and V. Y. Alakhov, 1995, Watersoluble block polycations as carriers for oligonucleotide delivery. Bioconjug. Chem. 6:639–643.

    PubMed  CAS  Google Scholar 

  44. Kabanov, A. V., 1999, Taking polycation gene delivery systems from in vitro to in vivo. Pharm. Sci. Tech. Today 2:365–372.

    CAS  Google Scholar 

  45. Vinogradov, S. V., T. K. Bronich and A. V. Kabanov, 1998, Self-assembly of polyaminepoly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug. Chem. 9:805–812.

    Article  PubMed  CAS  Google Scholar 

  46. Nguyen, H. K., P. Lemieux, S. V. Vinogradov, C. L. Gebhart, N. Guerin, G. Paradis, T. K. Bronich, V. Y. Alakhov and A. V. Kabanov, 2000, Evaluation of polyetherpolyethyleneimine graft copolymers as gene transfer agents. Gene Ther 7:126–138.

    Article  PubMed  CAS  Google Scholar 

  47. Gebhart, C. L. and A. V. Kabanov, 2001, Evaluation of polyplexes as gene transfer agents. J. Contr. Release 73:401–416.

    CAS  Google Scholar 

  48. Fraser, J. R., T. C. Laurent, H. Pertoft and E. Baxter, 1981, Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 200:415–424.

    PubMed  CAS  Google Scholar 

  49. Kissel, M., P. Peschke, V. Subr, K. Ulbrich, J. Schuhmacher, J. Debus and E. Friedrich, 2001, Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. PDA J Pharm Sci Technol 55:191–201.

    PubMed  CAS  Google Scholar 

  50. Jewell, R. C., S. P. Khor, D. F. Kisor, K. A. LaCroix and W. A. Wargin, 1997, Pharmacokinetics of RheothRx injection in healthy male volunteers. J. Pharm. Sci. 86:808–812.

    Article  PubMed  CAS  Google Scholar 

  51. Mitra, G., S. Mumtaz and B. K. Bachhawat, 1993, Enhanced stability and therapeutic utility of proteins upon conjugation with hydrophilic polymers. Hindustan Antibiot Bull 35:133–156.

    PubMed  CAS  Google Scholar 

  52. Hoste, K., E. Schacht and L. Seymour, 2000, New derivatives of polyglutamic acid as drug carrier systems. J Control Release 64:53–61.

    Article  PubMed  CAS  Google Scholar 

  53. Douglas, S. J., S. S. Davis and L. Illum, 1987, Nanoparticles in drug delivery. Crit Rev. Ther Drug Carrier Syst 3:233–261.

    PubMed  CAS  Google Scholar 

  54. Jung, T., W. Kamm, A. Breitenbach, E. Kaiserling, J. X. Xiao and T. Kissel, 2000, Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm 50:147–160.

    PubMed  CAS  Google Scholar 

  55. Darney, P. D., 1994, Hormonal implants: contraception for a new century. Am J Obstet. Gynecol 170:1536–43.

    PubMed  CAS  Google Scholar 

  56. Rothen-Weinhold, A., K. Besseghir, Y. De Zelicourt and R. Gurny, 1998, Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue. J Control Release 52:205–213.

    Article  PubMed  CAS  Google Scholar 

  57. Petrov, R. V., R. M. Khaitov, A. A. Mikhailova, V. M. Manko and V. A. Kabanov, 1984, Cell interactions and vaccines of tomorrow. Mir publishers, Moscow.

    Google Scholar 

  58. Maheshwari, A., R. I. Mahato, J. McGregor, S. Han, W. E. Samlowski, J. S. Park and S. W. Kim, 2000, Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol. Ther. 2:121–130.

    Article  PubMed  CAS  Google Scholar 

  59. Koh, J. J., K. S. Ko, M. Lee, S. Han, J. S. Park and S. W. Kim, 2000, Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther. 7:2099–2104.

    Article  PubMed  CAS  Google Scholar 

  60. Ko, K. S., M. Lee, J. J. Koh and S. W. Kim, 2001, Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Mol Ther 4:313–316.

    Article  PubMed  CAS  Google Scholar 

  61. Thorpe, P. E. and F. J. Burrows, 1995, Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treat 36:237–251.

    Article  PubMed  CAS  Google Scholar 

  62. Goodwin, D. A. and C. F. Meares, 1999, Pretargeted peptide imaging and therapy. Cancer. Biother Radiopharm 14:145–152.

    PubMed  CAS  Google Scholar 

  63. Torchilin, V. P., 1998, In vitro and in vivo availability of liposomes, In Self-assembling. complexes for gene delivery: From laboratory to clinical trial (A. V. Kabanov, P. L. Felgner and L. W. Seymour eds), John Wiley, Chichester, New York, Weinheim, Brisbane, Singapore, Toronto pp 277–293.

    Google Scholar 

  64. Poste, G., C. Bucana, A. Raz, P. Bugelski, R. Kirsh and I. J. Fidler, 1983, Site-specific (targeted) drug delivery in cancer therapy. Biotech 1:869–868.

    CAS  Google Scholar 

  65. Judson, I., J. A. Radford, M. Harris, J. Y. Blay, Q. van Hoesel, A. le Cesne, A. T. van Oosterom, M. J. Clemons, C. Kamby, C. Hermans, J. Whittaker, E. Donato di Paola, J. Verweij and S. Nielsen, 2001, Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 37:870–877.

    Article  PubMed  CAS  Google Scholar 

  66. Shi, N. and W. M. Pardridge, 2000, Noninvasive gene targeting to the brain. Proc Natl. Acad Sci U S A 97:7567–7572.

    PubMed  CAS  Google Scholar 

  67. Torchilin, V. P., 2000, Drug targeting. Eur J Pharm Sci 11Suppl 2:S81–S91.

    PubMed  CAS  Google Scholar 

  68. Yokoyama, M., T. Okano, Y. Sakurai, K. Kataoka and S. Inoue, 1989, Stabilization of disulfide linkage in drug-polymer-immunoglobulin conjugate by microenvironmental control. Biochem. Biophys. Res. Commun. 164:1234–1239.

    Article  PubMed  CAS  Google Scholar 

  69. Khaw, B. A., J. daSilva, I. Vural, J. Narula and V. P. Torchilin, 2001, Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes. J. Control Release 75:199–210.

    Article  PubMed  CAS  Google Scholar 

  70. Vinogradov, S., E. Batrakova, S. Li and A. Kabanov, 1999, Polyion Complex Micelles with Protein-Modified Corona for Receptor-Mediated Delivery of Oligonucleotides into Cells. Bioconjug. Chem. 10:851–860.

    Article  PubMed  CAS  Google Scholar 

  71. Lubbe, A. S., C. Alexiou and C. Bergemann, 2001, Clinical applications of magnetic drug targeting. J Surg Res 95:200–206.

    PubMed  CAS  Google Scholar 

  72. Rudge, S., C. Peterson, C. Vessely, J. Koda, S. Stevens and L. Catterall, 2001, Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J. Control Release 74:335–340.

    Article  PubMed  CAS  Google Scholar 

  73. Maeda, H., T. Sawa and T. Konno, 2001, Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47–61.

    Article  PubMed  CAS  Google Scholar 

  74. Maeda, H., 2001, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme. Regul 41:189–207.

    PubMed  CAS  Google Scholar 

  75. Duncan, R., 1999, Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. Technol. Today. 2:441–449.

    PubMed  CAS  Google Scholar 

  76. Noguchi, Y., J. Wu, R. Duncan, J. Strohalm, K. Ulbrich, T. Akaike and H. Maeda, 1998, Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 89:307–314.

    PubMed  CAS  Google Scholar 

  77. Malik, N., E. G. Evagorou and R. Duncan, 1999, Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10:767–776.

    PubMed  CAS  Google Scholar 

  78. Huuskonen, J., 2001, Estimation of aqueous solubility in drug design. Comb Chem High. Throughput Screen 4:311–316.

    PubMed  CAS  Google Scholar 

  79. Alakhov, V., G. Pietrzynski and A. Kabanov, 2001, Combinatorial approaches to formulation development. Curr Opin Drug Discov Devel 4:493–501.

    PubMed  CAS  Google Scholar 

  80. Wike-Hooley, J. L., J. Haveman and H. S. Reinhold, 1984, The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2:343–366.

    PubMed  CAS  Google Scholar 

  81. Solomatin, S. V., T. K. Bronich, V. A. Kabanov, A. Eisenberg and A. V. Kabanov, 2001, Block ionomer complexes: novel environmentally responsive materials. Polym. Prepr. 42:107–108.

    CAS  Google Scholar 

  82. Ponnappa, B. C., I. Dey, G. C. Tu, F. Zhou, M. Aini, Q. N. Cao and Y. Israel, 2001, In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats. J. Pharmacol Exp Ther 297:1129–1136.

    PubMed  CAS  Google Scholar 

  83. Drummond, D. C., M. Zignani and J. Leroux, 2000, Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 39:409–460.

    Article  PubMed  CAS  Google Scholar 

  84. Straubinger, R. M., N. Duzgunes and D. Papahadjopoulos, 1985, pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett 179:148–154.

    Article  PubMed  CAS  Google Scholar 

  85. Liu, D. and L. Huang, 1989, Role of cholesterol in the stability of pH-sensitive, large unilamellar liposomes prepared by the detergent-dialysis method. Biochim Biophys Acta 981:254–260.

    PubMed  CAS  Google Scholar 

  86. Reddy, J. A. and P. S. Low, 2000, Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release 64:27–37.

    Article  PubMed  CAS  Google Scholar 

  87. Parente, R. A., L. Nadasdi, N. K. Subbarao and F. C. Szoka, Jr., 1990, Association of a pH-sensitive peptide with membrane vesicles: role of amino acid sequence. Biochemistry 29:8713–8719.

    PubMed  CAS  Google Scholar 

  88. Ishida, T., M. J. Kirchmeier, E. H. Moase, S. Zalipsky and T. M. Allen, 2001, Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta 1515:144–158.

    PubMed  CAS  Google Scholar 

  89. Meyer, O., D. Papahadjopoulos and J. C. Leroux, 1998, Copolymers of Nisopropylacrylamide can trigger pH sensitivity to stable liposomes. FEBS Lett 421:61–64.

    Article  PubMed  CAS  Google Scholar 

  90. Leroux, J., E. Roux, D. Le Garrec, K. Hong and D. C. Drummond, 2001, Nisopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J Control Release 72:71–84.

    Article  PubMed  CAS  Google Scholar 

  91. Kohori, F., K. Sakai, T. Aoyagi, M. Yokoyama, M. Yamato, Y. Sakurai and T. Okano, 1999, Control of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-bpoly( D,L-lactide). Colloids Surf., B: Biointerfaces 16:195–205.

    Article  CAS  Google Scholar 

  92. Munshi, N., N. Rapoport and W. G. Pitt, 1997, Ultrasonic activated drug delivery from Pluronic P-105 micelles. Cancer Lett. 118:13–19.

    Article  PubMed  CAS  Google Scholar 

  93. Rapoport, N. Y., J. N. Herron, W. G. Pitt and L. Pitina, 1999, Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound on the intracellular drug uptake. J. Controlled Release 58:153–162.

    Article  CAS  Google Scholar 

  94. Husseini, G., G. D. Myrup, W. G. Pitt, D. A. Christensen and N. Y. Rapoport, 2000, Factors affecting acoustically triggered release of drugs from polymeric micelles. J. Controlled Release 69:43–52.

    Article  CAS  Google Scholar 

  95. Stayton, P. S., A. S. Hoffman, N. Murthy, C. Lackey, C. Cheung, P. Tan, L. A. Klumb, A. Chilkoti, F. S. Wilbur and O. W. Press, 2000, Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics. J Control Release 65:203–220.

    Article  PubMed  CAS  Google Scholar 

  96. Hoffman, A. S., P. S. Stayton, V. Bulmus, G. Chen, J. Chen, C. Cheung, A. Chilkoti, Z. Ding, L. Dong, R. Fong, C. A. Lackey, C. J. Long, M. Miura, J. E. Morris, N. Murthy, Y. Nabeshima, T. G. Park, O. W. Press, T. Shimoboji, S. Shoemaker, H. J. Yang, N. Monji, R. C. Nowinski, C. A. Cole, J. H. Priest, J. M. Harris, K. Nakamae, T. Nishino and T Miyata, 2000, Founder’s Award, Society for Biomaterials. Sixth World Biomaterials Congress 2000, Kamuela, HI,May 15–20, 2000. Really smart bioconjugates of smart polymers and receptor proteins. J Biomed Mater Res 52:577–586.

    Article  PubMed  CAS  Google Scholar 

  97. Lackey, C. A., N. Murthy, O. W. Press, D. A. Tirrell, A. S. Hoffman and P. S. Stayton, 1999, Hemolytic activity of pH-responsive polymer-streptavidin bioconjugates. Bioconjug. Chem 10:401–405.

    Article  PubMed  CAS  Google Scholar 

  98. Murthy, N., J. R. Robichaud, D. A. Tirrell, P. S. Stayton and A. S. Hoffman, 1999, The design and synthesis of polymers for eukaryotic membrane disruption. J Control Release 61:137–143.

    Article  PubMed  CAS  Google Scholar 

  99. Cheung, C. Y., N. Murthy, P. S. Stayton and A. S. Hoffman, 2001, A pH-sensitive polymer that enhances cationic lipid-mediated gene transfer. Bioconjug Chem 12:906–910.

    Article  PubMed  CAS  Google Scholar 

  100. Kyriakides, T. R., C. Y. Cheung, N. Murthy, P. Bornstein, P. S. Stayton and A. S. Hoffman, 2002, pH-sensitive polymers that enhance intracellular drug delivery in vivo. J. Control Release 78:295–303.

    Article  PubMed  CAS  Google Scholar 

  101. Tachibana, R., H. Harashima, M. Shono, M. Azumano, M. Niwa, S. Futaki and H. Kiwada, 1998, Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking. Biochem Biophys Res Commun 251:538–544.

    Article  PubMed  CAS  Google Scholar 

  102. Kabanov, A. V., A. V. Levashov and V. Y. Alakhov, 1989, Lipid modification of proteins and their membrane transport. Protein Eng. 3:39–42.

    Article  PubMed  CAS  Google Scholar 

  103. Kabanov, A. V., A. V. Ovcharenko, N. S. Melik-Hubarov, A. I. Bannikov, V. Alakhov, V. I. Kiselev, P. G. Sveshnikov, O.I. Kiselev, A. V. Levashov and E. S. Severin, 1989, Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett. 250:238–240.

    Article  PubMed  CAS  Google Scholar 

  104. Kabanov, A. V., V. Y. Alakhov and V. P. Chekhonin, 1992, Enhancement of macromolecule penetration into cells and nontraditional drug delivery systems, In, Harwood Academic Publishers, Glasgow pp 1–77.

    Google Scholar 

  105. Slepnev, V. I., L. Phalente, H. Labrousse, N. S. Melik-Nubarov, V. Mayau, B. Goud, G. Buttin and A. V. Kabanov, 1995, Fatty acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian cells. Bioconjug. Chem. 6:608–615.

    Article  PubMed  CAS  Google Scholar 

  106. Alakhov, V., A. V. Kabanov, E. V. Batrakova, I. A. Koromyslova, A. V. Levashov and E. S. Severin, 1990, Increasing cytostatic effects of ricin A chain and Staphylococcus aureus enterotoxin A through in vitro hydrophobization with fatty acid residues. Biotechnol. Appl. Biochem. 12:94–98.

    PubMed  CAS  Google Scholar 

  107. Oda, T. and H. Maeda, 1987, Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrenemaleic acid copolymer. Cancer Res 47:3206–3211.

    PubMed  CAS  Google Scholar 

  108. Oda, T., F. Sato and H. Maeda, 1987, Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH. J Natl Cancer. Inst 79:1205–1211.

    PubMed  CAS  Google Scholar 

  109. Slepnev, V. P., 1992, Modification of proteins for transport of biologically active compounds within the cell, Dissertation, Moscow State University.

    Google Scholar 

  110. Gebhart, C. L., S. Sriadibhatla, S. Vinogradov and A. Kabanov, 2001, Pluronicpolyethyleneimine conjugates for gene delivery. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 42:119–120.

    CAS  Google Scholar 

  111. Batrakova, E. V., S. Li, S. V. Vinogradov, V. Y. Alakhov, D. W. Miller and A. V. Kabanov, 2001, Mechanism of pluronic effect on p-glycoprotein efflux system in blood brain barrier: contributions of energy depletion and membrane fluidization. J. Pharmacol. Exp. Ther. 299:483–493.

    PubMed  CAS  Google Scholar 

  112. Snyder, E. L. and S. F. Dowdy, 2001, Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. Curr Opin Mol Ther 3:147–152.

    PubMed  CAS  Google Scholar 

  113. Schwartz, J. J. and S. Zhang, 2000, Peptide-mediated cellular delivery. Curr Opin Mol. Ther 2:162–167.

    PubMed  CAS  Google Scholar 

  114. Torchilin, V. P., R. Rammohan, V. Weissig and T. S. Levchenko, 2001, TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A 98:8786–8791.

    Article  PubMed  CAS  Google Scholar 

  115. Ambudkar, S. V., S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan and M. M. Gottesman, 1999, Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Ann. Rev. Pharmacol. Toxicol. 39:361–398.

    Article  CAS  Google Scholar 

  116. Zhang, Y., H. Han, W. F. Elmquist and D. W. Miller, 2000, Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res. 876:148–153.

    PubMed  CAS  Google Scholar 

  117. Naito, S., A. Yokomizo and H. Koga, 1999, Mechanisms of drug resistance in chemotherapy for urogenital carcinoma. Int. J. Urol. 6:427–439.

    Article  PubMed  CAS  Google Scholar 

  118. Nooter, K. and G. Stoter, 1996, Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract. 192:768–780.

    PubMed  CAS  Google Scholar 

  119. Minko, T., P. Kopeckova, V. Pozharov and J. Kopecek, 1998, HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release 54:223–233.

    Article  PubMed  CAS  Google Scholar 

  120. Minko, T., P. Kopeckova and J. Kopecek, 1999, Chronic exposure to HPMA copolymer-bound adriamycin does noduce multidrug resistance in a human ovarian carcinoma cell line. J Control Release 59:133–148.

    Article  PubMed  CAS  Google Scholar 

  121. Tijerina, M., K. D. Fowers, P. Kopeckova and J. Kopecek, 2000, Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Biomaterials 21:2203–2210.

    Article  PubMed  CAS  Google Scholar 

  122. Omelyanenko, V., P. Kopeckova, C. Gentry and J. Kopecek, 1998, Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J. Control Release 53:25–37.

    Article  PubMed  CAS  Google Scholar 

  123. Miyamoto, Y., T. Oda and H. Maeda, 1990, Comparison of the cytotoxic effects of the high-and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro. Cancer Res 50:1571–1575.

    PubMed  CAS  Google Scholar 

  124. Minko, T., P. Kopeckova and J. Kopecek, 2001, Preliminary evaluation of caspasesdependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release 71:227–237.

    Article  PubMed  CAS  Google Scholar 

  125. Batrakova, E. V., S. Li, W. F. Elmquist, D. W. Miller, V. Y. Alakhov and A. V. Kabanov, 2001, Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br. J. Cancer 85:1987–1997.

    Article  PubMed  CAS  Google Scholar 

  126. Alakhov, V. Y., E. Y. Moskaleva, E. V. Batrakova and A. V. Kabanov, 1996, Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug. Chem. 7:209–216.

    Article  PubMed  CAS  Google Scholar 

  127. Batrakova, E. V., S. Li, D. W. Miller and A. V. Kabanov, 1999, Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. 16:1366–1372.

    PubMed  CAS  Google Scholar 

  128. Venne, A., S. Li, R. Mandeville, A. Kabanov and V. Alakhov, 1996, Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. 56:3626–3629.

    PubMed  CAS  Google Scholar 

  129. Pifferi, G., P. Santoro and M. Pedrani, 1999, Quality and functionality of excipients. Farmaco 54:1–14.

    Article  PubMed  CAS  Google Scholar 

  130. Bomford, R., 1981, The adjuvant activity of fatty acid esters. The role of acyl chain length and degree of saturation. Immunology 44:187–192.

    PubMed  CAS  Google Scholar 

  131. Hunter, R., M. Olsen and S. Buynitzky, 1991, Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody. Vaccine 9:250–256.

    Article  PubMed  CAS  Google Scholar 

  132. Hunter, R., F. Strickland and F. Kezdy, 1981, The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance. J. Immunol. 127:1244–1250.

    PubMed  CAS  Google Scholar 

  133. Hunter, R. L. and B. Bennett, 1984, The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers. J. Immunol. 133:3167–3175.

    PubMed  CAS  Google Scholar 

  134. Hunter, R. L. and B. Bennett, 1986, The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces. Scand. J. Immunol. 23:287–300.

    PubMed  CAS  Google Scholar 

  135. Hunter, R. L., J. McNicholl and A. A. Lal, 1994, Mechanisms of action of nonionic block copolymer adjuvants. AIDS Res Hum Retroviruses 10:S95–S98.

    PubMed  CAS  Google Scholar 

  136. Allison, A. C. and N. E. Byars, 1986, An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Methods 95:157–168.

    Article  PubMed  CAS  Google Scholar 

  137. Allison, A. C. and N. E. Byars, 1990, Adjuvant formulations and their mode of action. Semin. Immunol. 2:369–374.

    PubMed  CAS  Google Scholar 

  138. Ke, Y., C. L. McGraw, R. L. Hunter and J. A. Kapp, 1997, Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways. Cell Immunol. 176:113–121.

    Article  PubMed  CAS  Google Scholar 

  139. Millet, P., M. L. Kalish, W. E. Collins and R. L. Hunter, 1992, Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine. Vaccine 10:547–550.

    Article  PubMed  CAS  Google Scholar 

  140. Takayama, K., M. Olsen, P. Datta and R. L. Hunter, 1991, Adjuvant activity of nonionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors. Vaccine 9:257–265.

    Article  PubMed  CAS  Google Scholar 

  141. Schmolka, I. R., 1972, Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. 6:571–582.

    Article  PubMed  CAS  Google Scholar 

  142. Rodeheaver, G., V. Turnbull, M. T. Edgerton, L. Kurtz and R. F. Edlich, 1976, Pharmacokinetics of a new skin wound cleanser. Am. J. Surg. 132:67–74.

    Article  PubMed  CAS  Google Scholar 

  143. Rodeheaver, G. T., L. Kurtz, B. J. Kircher and R. F. Edlich, 1980, Pluronic F-68: a promising new skin wound cleanser. Ann. Emerg. Med. 9:572–576.

    PubMed  CAS  Google Scholar 

  144. Nalbandian, R. M., R. L. Henry, K. W. Balko, D. V. Adams and N. R. Neuman, 1987, Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs. J. Biomed. Mater. Res. 21:1135–1148.

    Article  PubMed  CAS  Google Scholar 

  145. Gear, A. J., T. B. Hellewell, H. R. Wright, P. M. Mazzarese, P. B. Arnold, G. T. Rodeheaver and R. F. Edlich, 1997, A new silver sulfadiazine water soluble gel. Burns 23:387–391.

    Article  PubMed  CAS  Google Scholar 

  146. Follis, F., B. Jenson, K. Blisard, E. Hall, R. Wong, R. Kessler, T. Temes and J. Wernly, 1996, Role of poloxamer 188 during recovery from ischemic spinal cord injury: a preliminary study. J. Invest. Surg. 9:149–156.

    PubMed  CAS  Google Scholar 

  147. Agren, M. S., 1998, An amorphous hydrogel enhances epithelialisation of wounds. Acta Derm. Venereol. 78:119–122.

    PubMed  CAS  Google Scholar 

  148. Cao, Y. L., E. Lach, T. H. Kim, A. Rodriguez, C. A. Arevalo and C. A. Vacanti, 1998, Tissue-engineered nipple reconstruction. Plast. Reconstr. Surg. 102:2293–2298.

    PubMed  CAS  Google Scholar 

  149. Vlahos, A., P. Yu, C. E. Lucas and A. M. Ledgerwood, 2001, Effect of a composite membrane of chitosan and poloxamer gel on postoperative adhesive interactions. Am. Surg. 67:15–21.

    PubMed  CAS  Google Scholar 

  150. Leach, R. E. and R. L. Henry, 1990, Reduction of postoperative adhesions in the rat uterine horn model with poloxamer 407. Am. J. Obstet. Gynecol. 162:1317–1319.

    PubMed  CAS  Google Scholar 

  151. Hannig, J., D. Zhang, D. J. Canaday, M. A. Beckett, R. D. Astumian, R. R. Weichselbaum and R. C. Lee, 2000, Surfactant sealing of membranes permeabilized by ionizing radiation. Radiat. Res. 154:171–177.

    PubMed  CAS  Google Scholar 

  152. Lee, R. C., D. J. Canaday and S. M. Hammer, 1993, Transient and stable ionic permeabilization of isolated skeletal muscle cells after electrical shock. J. Burn. Care. Rehabil. 14:528–540.

    PubMed  CAS  Google Scholar 

  153. Lee, R. C., J. Hannig, K. L. Matthews, A. Myerov and C. T. Chen, 1999, Pharmaceutical therapies for sealing of permeabilized cell membranes in electrical injuries. Ann. NY Acad. Sci. 888:266–273.

    PubMed  CAS  Google Scholar 

  154. Batrakova, E. V., S. Li, V. Y. Alakhov and A. V. Kabanov, 2000, Selective energy depletion and sensitization of multiple drug resistant cancer cells by Pluronic block copolymers. Polym. Prepr. 41:1639–1640.

    CAS  Google Scholar 

  155. Batrakova, E. V., S. Lee, S. Li, A. Venne, V. Alakhov and A. Kabanov, 1999, Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm. Res. 16:1373–1379.

    PubMed  CAS  Google Scholar 

  156. Demoy, M., T. Minko, P. Kopeckova and J. Kopecek, 2000, Time-and concentrationdependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release 69:185–196.

    Article  PubMed  CAS  Google Scholar 

  157. Keatley, K. L., 1999, A review of US EPA and FDA requirements for electronic records, electronic signatures, and electronic submissions. Qual Assur 7:77–89.

    PubMed  CAS  Google Scholar 

  158. Nishi, H., 1999, Capillary electrophoresis of drugs: current status in the analysis of pharmaceuticals. Electrophoresis 20:3237–3258.

    Article  PubMed  CAS  Google Scholar 

  159. Kabanov, A. V., I. R. Nazarova, I. V. Astafieva, E. V. Batrakova, V. Y. Alakhov, A. A. Yaroslavov and V. A. Kabanov, 1995, Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules 28:2303–2314.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, Department of Pharmaceutical Sciences, University of Nebraska Medical Center 986025 Nebraska Medical Center, Omaha, NE, 68198-6025, USA

    Alexander V. Kabanov

  2. Institute of Biomedical Engineering, Tokyo Women’s Medical University, 8-1 Kawadacho, Shinjuku, Tokyo, 162, Japan

    Teruo Okano

Authors
  1. Alexander V. Kabanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teruo Okano
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kumamoto University School of Medicine, Kumamoto, Japan

    Hiroshi Maeda

  2. University of Nebraska Medical Center, Omaha, Nebraska

    Alexander Kabanov

  3. University of Tokyo, Tokyo, Japan

    Kazunori Kataoka

  4. Tokyo Women’s Medical College, Tokyo, Japan

    Teruo Okano

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Kabanov, A.V., Okano, T. (2004). Challenges in Polymer Therapeutics. In: Maeda, H., Kabanov, A., Kataoka, K., Okano, T. (eds) Polymer Drugs in the Clinical Stage. Advances in Experimental Medicine and Biology, vol 519. Springer, Boston, MA. https://doi.org/10.1007/0-306-47932-X_1

Download citation

  • DOI: https://doi.org/10.1007/0-306-47932-X_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-47471-2

  • Online ISBN: 978-0-306-47932-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation